Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
280
57
63
48
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
1.4%
4 terminated/withdrawn out of 280 trials
92.3%
+5.8% vs industry average
18%
49 trials in Phase 3/4
2%
1 of 48 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (280)
VAH vs VA in Newly Diagnosed Elderly AML
Role: lead
Acute Myocardial Infarction Clinical Cohort
Role: collaborator
Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients
Role: lead
The Effect of PPI on Endoscopic Treatment of WON: a Multicenter Randomized Controlled Trial.
Role: collaborator
Early-phase Study of ART002g1 Injection in HeFH: Safety, Tolerability and Preliminary Efficacy
Role: lead
An Assistant Model for IRD Care Needs: A Randomized Control Trial
Role: lead
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
Role: lead
6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors
Role: lead
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
Role: lead
Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
Role: lead
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
Role: lead
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Role: collaborator
Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
Role: lead
Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
Role: lead
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Role: lead
Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery
Role: lead
Application of Quantitative Hemorrhage Detection in Fetomaternal Hemorrhage Syndrome for the Diagnosis of Hemolytic Disease of the Newborn
Role: lead
Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy
Role: lead
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Role: collaborator
Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.
Role: collaborator